News and Views


Nature Biotechnology 23, 556 - 557 (2005)
doi:10.1038/nbt0505-556

Tunable antibodies

Louis M Weiner1 & Paul Carter2

  1. Louis M. Weiner is at the Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA. e-mail: Louis.Weiner@fccc.edu
  2. Paul Carter is at Seattle Genetics Corporation, 21823 30th Drive SE, Bothell, Washington 98021, USA. e-mail: pcarter@seagen.com


A recent Keystone meeting highlighted the progress in generating effective anti-cancer antibodies by manipulating antibody binding affinity and their ability to support ADCC.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

REVIEWS

Potent antibody therapeutics by design

Nature Reviews Immunology Review (01 May 2006)

NEWS AND VIEWS

The rollercoaster ride to anti-cancer antibodies

Nature Biotechnology Research News (01 May 2003)